Equillium, Inc.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clin…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Equillium, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Equillium, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Equillium, Inc..